The circulating glycosaminoglycan signature of respiratory

Journal of Biological Chemistry

Volumn 289, Issue 12, 2014, Pages 8194-8202

  Schmidt, Eric P ^a,b   Li, Guoyun ^c,d   Li, Lingyun ^d   Fu, Li ^d   Yang, Yimu ^a   Overdier, Katherine H ^b   Douglas, Ivor S ^a,b   Linhardt, Robert J ^d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c OCEAN UNIVERSITY OF CHINA   (China)

^d Research Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; INTENSIVE CARE UNITS; MASS SPECTROMETRY; ORGANIC ACIDS; PLASMAS; SULFUR COMPOUNDS;

ACID CONCENTRATIONS; CHONDROITIN SULFATES; GLYCOSAMINOGLYCANS; HEPARAN SULFATES; LENGTH OF STAY; PATHOPHYSIOLOGIC; PLASMA MEASUREMENT; RESPIRATORY FAILURE;

BIOLOGICAL ORGANS;

BIOLOGICAL MARKER; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BIOCHEMICAL COMPOSITION; BLOOD LEVEL; BLOOD SAMPLING; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; EXTRACELLULAR MATRIX; FEMALE; GLYCOBIOLOGY; GLYCOCALYX; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIQUID CHROMATOGRAPHY; LUNG ASPIRATION; MALE; MASS SPECTROMETRY; MIDDLE AGED; PANCREATITIS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SULFATION; VENTILATED PATIENT;

CHONDROITIN SULFATE; ENDOTHELIAL GLYCOCALYX; GLYCOBIOLOGY; HEPARAN SULFATE; HYALURONATE; LUNG INJURY; RESPIRATORY FAILURE; SEPSIS;

ADULT; AGED; CHONDROITIN SULFATES; CRITICAL ILLNESS; FEMALE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY INSUFFICIENCY;

EID: 84896905926     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.539452     Document Type: Article

References (35)

1. Weinbaum, S., Tarbell, J. M., and Damiano, E. R. (2007) The Structure and Function of the Endothelial Glycocalyx Layer. Annu. Rev. Biomed. Eng. 9, 121-167 (Pubitemid 350246654)
2. Schmidt, E. P., Yang, Y., Janssen, W. J., Gandjeva, A., Perez, M. J., Barthel, L., Zemans, R. L., Bowman, J. C., Koyanagi, D. E., Yunt, Z. X., Smith, L. P., Cheng, S. S., Overdier, K. H., Thompson, K. R., Geraci, M. W., Douglas, I. S., Pearse, D. B., and Tuder, R. M. (2012) The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18, 1217-1223
3. Curry, F. E., and Adamson, R. H. (2012) Endothelial Glycocalyx: Permeability Barrier and Mechanosensor. Ann. Biomed. Eng. 40, 828-839
4. Florian, J. A., Kosky, J. R., Ainslie, K., Pang, Z., Dull, R. O., and Tarbell, J. M. (2003) Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ. Res. 93, e136-e142
5. Burke-Gaffney, A., and Evans, T. (2012) Lest we forget the endothelial glycocalyx in sepsis. Crit. Care 16, 121
6. Johansson, P. I., Stensballe, J., Rasmussen, L. S., and Ostrowski, S. R. (2011) A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 254, 194-200
7. Myburgh, J. A., and Mythen, M. G. (2013) Resuscitation Fluids. N. Engl. J. Med. 369, 1243-1251
8. Nieuwdorp, M., Meuwese, M. C., Mooij, H. L., van Lieshout, M. H., Hayden, A., Levi, M., Meijers, J. C., Ince, C., Kastelein, J. J., Vink, H., and Stroes, E. S. (2009) Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 202, 296-303
9. Donati, A., Damiani, E., Domizi, R., Romano, R., Adrario, E., Pelaia, P., Ince, C., and Singer, M. (2013). Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvasc. Res. 10.1016/j.mvr.2013.08.007
10. Steppan, J., Hofer, S., Funke, B., Brenner, T., Henrich, M., Martin, E., Weitz, J., Hofmann, U., and Weigand, M. A. (2011) Sepsis and Major Abdominal Surgery Lead to Flaking of the Endothelial Glycocalix. J. Surg. Res. 165, 136-141
11. Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L., and Bodelsson, M. (2008) Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock. 30, 623-627
12. Yagmur, E., Koch, A., Haumann, M., Kramann, R., Trautwein, C., and Tacke, F. (2012) Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity. Clin. Biochem. 45, 82-87
13. Sallisalmi, M., Tenhunen, J., Yang, R., Oksala, N., and Pettilä, V. (2012) Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiol Scand 56, 316-322
14. Ledin, J., Staatz, W., Li, J. P., Götte, M., Selleck, S., Kjellén, L., and Spillmann, D. (2004) Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production. J. Biol. Chem. 279, 42732-42741 (Pubitemid 39372160)
15. Jiang, D., Liang, J., and Noble, P. W. (2011) Hyaluronan as an Immune Regulator in Human Diseases. Physiol. Rev. 91, 221-264
16. Yang, B., Chang, Y., Weyers, A. M., Sterner, E., and Linhardt, R. J. (2012) Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography/mass spectrometry. J Chromatogr A 1225, 91-98
17. Esko, J. D., and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173 (Pubitemid 32656238)
18. Goetz, R., and Mohammadi, M. (2013) Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol. 14, 166-180
19. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., Homer, R. J., Goldstein, D. R., Bucala, R., Lee, P. J., Medzhitov, R., and Noble, P. W. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med 11, 1173-1179 (Pubitemid 43093664)
20. Yang, B., Weyers, A., Baik, J. Y., Sterner, E., Sharfstein, S., Mousa, S. A., Zhang, F., Dordick, J. S., and Linhardt, R. J. (2011) Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal. Biochem. 415, 59-66
21. Zhang, F., Sun, P., Muñoz, E., Chi, L., Sakai, S., Toida, T., Zhang, H., Mousa, S., and Linhardt, R. J. (2006) Microscale isolation and analysis of heparin from plasma using an anion-exchange spin column. Anal. Biochem. 353, 284-286 (Pubitemid 43792340)
22. Shaya, D., Tocilj, A., Li, Y., Myette, J., Venkataraman, G., Sasisekharan, R., and Cygler, M. (2006) Crystal Structure of Heparinase II from Pedobacter heparinus and Its Complex with a Disaccharide Product. J. Biol. Chem. 281, 15525-15535 (Pubitemid 43855145)
23. Yoshida, E., Arakawa, S., Matsunaga, T., Toriumi, S., Tokuyama, S., Morikawa, K., and Tahara, Y. (2002) Cloning, sequencing, and expression of the gene from bacillus circulans that codes for a heparinase that degrades both heparin and heparan sulfate. Biosci Biotechnol. Biochem. 66, 1873-1879 (Pubitemid 39246794)
24. Kitagawa, H., Kinoshita, A., and Sugahara, K. (1995) Microanalysis of Glycosaminoglycan-Derived Disaccharides Labeled with the Fluorophore 2-Aminoacridone by Capillary Electrophoresis and High-Performance Liquid Chromatography. Anal. Biochem. 232, 114-121
25. Escobar Galvis, M. L., Jia, J., Zhang, X., Jastrebova, N., Spillmann, D., Gottfridsson, E., van Kuppevelt, T. H., Zcharia, E., Vlodavsky, I., Lindahl, U., and Li, J. P. (2007) Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate. Nat Chem Biol 3, 773-778 (Pubitemid 350126870)
26. Sandwall, E., Bodevin, S., Nasser, N. J., Nevo, E., Avivi, A., Vlodavsky, I., and Li, J. P. (2009) Molecular Structure of Heparan Sulfate from Spalax. J. Biol. Chem. 284, 3814-3822
27. Peterson, S. B., and Liu, J. (2013). Multi-faceted substrate specificity of heparanase. Matrix Biol. 32, 223-227
28. Wei, W., Miller, R. L., and Leary, J. A. (2013) Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes. Anal. Chem. 85, 5917-5923
29. Parish, C. R., Hindmarsh, E. J., Bartlett, M. R., Staykova, M. A., Cowden, W. B., and Willenborg, D. O. (1998) Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. Immunol. Cell Biol. 76, 104-113 (Pubitemid 28194703)
30. Seeley, E. J., Matthay, M. A., and Wolters, P. J. (2012) Inflection points in sepsis biology: from local defense to systemic organ injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L355-L363
31. Gao, F., Koenitzer, J. R., Tobolewski, J. M., Jiang, D., Liang, J., Noble, P. W., and Oury, T. D. (2008) Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem. 283, 6058-6066
32. Berg, S. (1997) Hyaluronan turnover in relation to infection and sepsis. J. Int. Med. 242, 73-77
33. McKee, R. F., Hodson, S., Dawes, J., Garden, O. J., and Carter, D. C. (1992) Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 33, 1549-1552
34. de Ru, M. H., van der Tol, L., van Vlies, N., Bigger, B.W., Hollak, C. E., Ijlst, L., Kulik, W., van Lenthe, H., Saif, M.A., Wagemans, T., van der Wal, W.M., Wanders, R.J., and Wijburg, F.A. (2013) Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after longterm enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans. J. Inherit. Metab. Dis. 36, 247-255
35. Pelosi, P., D'Onofrio, D., Chiumello, D., Paolo, S., Chiara, G., Capelozzi, V. L., Barbas, C. S., Chiaranda, M., and Gattinoni, L. (2003) Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur. Respir. J. Suppl. 42, 48s-56s